Treatment of hyperkeratotic skin diseases with R 68151, a topical 5-lipoxygenase inhibitor: four case reports.
Mariën
K
K
Morren
M
M
Degreef
H
H
De Doncker
P
P
Rooman
R P
RP
Cauwenbergh
G
G
D000293:Adolescent; D000328:Adult; D001094:Arachidonate 5-Lipoxygenase; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D007223:Infant; D007642:Keratosis / Q000188:drug therapy*; D016859:Lipoxygenase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009824:Ointments; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*
D007093:Imidazoles; D016859:Lipoxygenase Inhibitors; D009824:Ointments; D010879:Piperazines; C064426:R 68151; D001094:Arachidonate 5-Lipoxygenase